Collectively, these data suggest that specific glutamate receptor subtypes, GluD2 in particular, could being part of, or directly associated with the DAPC in the cerebellum, and their expression and function could be altered in dystrophinopathy. This evidence concerns the gene GLUD2 and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.